In ACP52C‐treated cancer cells, we also observed an increase in DNA strand breaks (SBs) and an upregulation of DNA damage responses (DDRs) markers, including γH2AX, as well as phosphorylated ATM, ATR, CHK1, and CHK2 (Figure 5A–C). The gene discussed is CHEK2; the disease is cancer.